Page 1 of Clinical Trials for "5,6-dimethylxanthenoneacetic acid", 18 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Last Updated: January 29, 2009
Condition(s): Prostate Cancer
2
Withdrawn
ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors
Last Updated: February 22, 2011
Condition(s): Tumors
3
Completed
Study of DMXAA (Now Known as ASA404) in Solid Tumors
Last Updated: March 17, 2009
Condition(s): Solid Tumors
4
Active, not recruiting
Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
Last Updated: October 30, 2010
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
5
Recruiting
Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Last Updated: September 27, 2011
Condition(s): Lung Cancer
6
Completed
A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors
Last Updated: August 31, 2011
Condition(s): Advanced Solid Tumors
7
Completed
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)
Last Updated: August 31, 2011
Condition(s): Non-small Cell Lung Cancer
8
Terminated
Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor
Last Updated: August 31, 2011
Condition(s): Solid Tumors
9
Suspended
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Last Updated: August 20, 2010
Condition(s): Urothelial Carcinoma
10
Completed
Phase I Safety Study of DMXAA in Refractory Tumors
Last Updated: March 4, 2009
Condition(s): Refractory Tumors
11
Terminated
An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404
Last Updated: August 31, 2011
Condition(s): Metastatic Cancer With Impaired Renal Function; Metastatic Cancer With Normal Renal Function
12
Terminated
An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function
Last Updated: August 31, 2011
Condition(s): Histologically-proven and Radiologically-confirmed Solid Tumors
13
Completed
Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors
Last Updated: August 31, 2011
Condition(s): Advanced or Recurrent Solid Tumors
14
Terminated
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
Last Updated: August 31, 2011
Condition(s): Metastatic Cancer
15
Terminated
A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies
Last Updated: August 31, 2011
Condition(s): Solid Tumor Malignancies
16
Terminated
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
Last Updated: May 2, 2012
Condition(s): Non-Small Cell Lung Cancer
17
Completed
Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Last Updated: January 29, 2009
Condition(s): Non-Small Cell Lung Cancer
18
Terminated
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
Last Updated: May 3, 2012
Condition(s): Non-Small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%225%2C6-dimethylxanthenoneacetic+acid%22

Page 1 of Clinical Trials for "5,6-dimethylxanthenoneacetic acid", 18 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About